Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Most drug screening methods use purified proteins, cultured cells, and/or small model organisms such as Xenopus, zebrafish, flies, or nematodes. These systems have proven successes in drug discovery, but they also have weaknesses. Although purified cellular components allow for identification of compounds with activity against specific targets, such systems lack the complex biological interactions present in cellular and organismal screens. In vivo systems overcome these weaknesses, but the lack of cellular permeability, efflux by cellular pumps, and/or toxicity can be major limitations. Xenopus laevis egg extract, a concentrated and biologically active cytosol, can potentially overcome these weaknesses. Drug interactions occur in a near-physiological milieu, thereby functioning in a "truer" endogenous manner than purified components. Also, Xenopus egg extract is a cell-free system that lacks intact plasma membranes that could restrict drug access to potential targets. Finally, Xenopus egg extract is readily manipulated at the protein level: Proteins are easily depleted or added to the system, an important feature for analyzing drug effects in disease states. Thus, Xenopus egg extract offers an attractive media for screening drugs that merges strengths of both in vitro and in vivo systems.
Bermudez,
Probing the biology of cell boundary conditions through confinement of Xenopus cell-free cytoplasmic extracts.
2017, Pubmed,
Xenbase
Bermudez,
Probing the biology of cell boundary conditions through confinement of Xenopus cell-free cytoplasmic extracts.
2017,
Pubmed
,
Xenbase Broadus,
Small-molecule high-throughput screening utilizing Xenopus egg extract.
2015,
Pubmed
,
Xenbase Chan,
In vitro study of nuclear assembly and nuclear import using Xenopus egg extracts.
2006,
Pubmed
,
Xenbase Chen,
Reconstitution Of β-catenin degradation in Xenopus egg extract.
2014,
Pubmed
,
Xenbase Cross,
Obtaining eggs from Xenopus laevis females.
2008,
Pubmed
,
Xenbase Cross,
Preparation and fractionation of Xenopus laevis egg extracts.
2008,
Pubmed
,
Xenbase Deming,
Study of apoptosis in vitro using the Xenopus egg extract reconstitution system.
2006,
Pubmed
,
Xenbase Edens,
A Cell-Free Assay Using Xenopus laevis Embryo Extracts to Study Mechanisms of Nuclear Size Regulation.
2016,
Pubmed
,
Xenbase Good,
Preparation of Cellular Extracts from Xenopus Eggs and Embryos.
2018,
Pubmed
,
Xenbase Kornbluth,
Analysis of apoptosis using Xenopus egg extracts.
2001,
Pubmed
,
Xenbase Landais,
A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway.
2009,
Pubmed
,
Xenbase Lebensohn,
Cdc42 and PI(4,5)P2-induced actin assembly in Xenopus egg extracts.
2006,
Pubmed
,
Xenbase Maresca,
Methods for studying spindle assembly and chromosome condensation in Xenopus egg extracts.
2006,
Pubmed
,
Xenbase Murray,
Cell cycle extracts.
1991,
Pubmed Murray,
Cyclin synthesis drives the early embryonic cell cycle.
1989,
Pubmed
,
Xenbase Newport,
Nuclear reconstitution in vitro: stages of assembly around protein-free DNA.
1987,
Pubmed
,
Xenbase Peterson,
Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation.
2004,
Pubmed
,
Xenbase Raspelli,
Xenopus egg extract to study regulation of genome-wide and locus-specific DNA replication.
2017,
Pubmed
,
Xenbase Salic,
Identifying small molecule inhibitors of the ubiquitin-proteasome pathway in Xenopus egg extracts.
2005,
Pubmed
,
Xenbase Shennan,
Xenopus egg extracts: a model system to study proprotein convertases.
2006,
Pubmed
,
Xenbase Thorne,
A biochemical screen for identification of small-molecule regulators of the Wnt pathway using Xenopus egg extracts.
2011,
Pubmed
,
Xenbase Verma,
Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain.
2004,
Pubmed
,
Xenbase Walter,
Regulated chromosomal DNA replication in the absence of a nucleus.
1998,
Pubmed
,
Xenbase Willis,
Study of the DNA damage checkpoint using Xenopus egg extracts.
2012,
Pubmed
,
Xenbase Zhang,
A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.
1999,
Pubmed